HemOnc Today Current Issue
The following articles appeared in the print edition of HemOnc Today.
Table of Contents
- Deeper understanding of disease biology may improve outcomes in triple-negative breast cancer
-
- Should neoadjuvant carboplatin be used for triple-negative breast cancer?
- Clinical pathways: A new target John Sweetenham, MD, FRCP, FACP
- Changing the paradigm of cytomegalovirus management among HSCT patients Roy F. Chemaly, MD, MPH, FACP, FIDSA
- Guidelines aim to reduce treatment disparities for people with HIV diagnosed with cancer
- Addition of enzalutamide to androgen deprivation reduces risk for prostate cancer metastases
- Cabozantinib induces antitumor activity for radioiodine-refractory thyroid cancer
- Diverse gut microbiota may protect gastrointestinal tract in acute graft-versus-host disease
- Esophagectomy prolongs esophageal cancer survival
-
- Exercise intervention improves arm mobility after lymph node dissection
- Financial burden common among adults with graft-versus-host disease
- Genetic marker linked to prolonged time on opioids after HSCT
- Lower radiation doses feasible for HPV-positive head and neck cancers
- Maintenance rituximab improves PFS in follicular lymphoma
- Nonmyeloablative haploidentical allogeneic bone marrow transplant feasible for sickle cell disease
- Patient-reported outcomes collected prior to HSCT predict clinical outcomes
- Physical evaluation may improve patient selection for bone marrow transplant
-
- Practical considerations must guide response assessment, toxicity management with immunotherapy
- Prognostic models could guide treatment for advanced urothelial cancer
- Racial disparities persist in stem cell transplant for multiple myeloma
- Salvage immunotherapy viable for non-small cell lung cancer
- Stand Up To Cancer dream team strives for ‘active interception’ of pancreatic cancer
- Targeted therapies effective for acute lymphoblastic leukemia
- Transplant physicians have ‘substantial concerns’ regarding palliative care services
- Unemployment rates high among survivors of allogeneic transplant
-
- Web-based intervention may help childhood cancer survivors stay physically active
- CVD risk may increase with breast cancer treatment
- One in five young women dependent on indoor tanning
- USPSTF recommends against ovarian cancer screening in asymptomatic women
- Lifetime physical inactivity increases risk for lung cancer
- Advanced gum disease increases risk for lung, colorectal cancer
- Tumor-treating fields for glioblastoma do not negatively impact quality of life
- Large tumor size, positive lymph nodes increase distant recurrence in ER-positive breast cancer
-
- Elimination of cost-sharing under ACA increases access to mammography
- Fitusiran lowers antithrombin levels in hemophilia A, B
- Cognitive impairment common among elderly with blood cancers
- Lifestyle factors associated with ischemic heart disease after hematopoietic cell transplantation
- Men with HIV who have sex with men have elevated incidence of anal cancer
- Screening for oral HPV ‘would be challenging’ due to low throat cancer risk
- Many men with penile cancer do not receive guideline-recommended care
- Mothers of children with cancer report lower income after diagnosis
-
- Lenvatinib-pembrolizumab combination receives breakthrough status for renal cell carcinoma
- FDA expands approval of Feraheme for iron deficiency anemia
- FDA expands Zytiga approval for prostate cancer
- FDA grants fast track designation to RM-1929 for HNSCC
- FDA places clinical hold on trial of axalimogene filolisbac and durvalumab after patient death
- FDA authorizes direct-to-consumer genetic test for three BRCA mutations
- FDA grants fast track designation to pamrevlumab for pancreatic cancer
- FDA grants priority review to ivosidenib for leukemia subtype
-
- FDA grants breakthrough therapy designation to GC4419 for severe oral mucositis
- FDA grants Keytruda priority review for advanced cervical cancer
- FDA grants YS-ON-001 orphan drug designation for pancreatic cancer
- FDA expands Verzenio approval for breast cancer
- Bariatric surgery reduces risk for certain cancers
- NYU Langone and Perlmutter Cancer Center appoint gastrointestinal medical oncology director
- Tisch Cancer Institute appoints director of Center for Carcinoid and Neuroendocrine Tumors
- Sarcoma Foundation of America to honor orthopedic surgeon
-
- Roswell Park Comprehensive Cancer Center professor to lead American College of Nuclear Medicine